Published in Strahlenther Onkol on January 01, 1990
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol (1997) 2.23
Biological effects after prenatal irradiation (embryo and fetus). A report of the International Commission on Radiological Protection. Ann ICRP (2003) 1.91
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Contiguous pattern spreading in patients with Hodgkin's disease. Radiother Oncol (1998) 1.55
Radiation induced CNS toxicity--molecular and cellular mechanisms. Br J Cancer (2001) 1.44
Radiotherapy for treatment of localized gastrointestinal non-Hodgkin's lymphoma. Radiother Oncol (1997) 1.43
Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.34
Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages. Eur J Neurosci (2001) 1.33
DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol (2013) 1.32
Effective doses to patients from paediatric cardiac catheterization. Br J Radiol (2000) 1.23
Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol (1999) 1.20
Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines. Int J Radiat Oncol Biol Phys (2001) 1.19
Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1993) 1.16
Tumor radiosensitivity prediction by the cytokinesis-block micronucleus assay. Radiat Res (1991) 1.14
Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology. Int J Radiat Biol (2002) 1.14
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo. Oncogene (2006) 1.13
Induction treatment before surgery for non-small cell lung cancer. Lung Cancer (2003) 1.12
Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer (1996) 1.11
Impact of localized radiotherapy on blood immune cells counts and function in humans. Radiother Oncol (1999) 1.10
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol (1996) 1.09
BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage. Int J Radiat Biol (2002) 1.07
Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? Eur J Nucl Med Mol Imaging (2005) 1.06
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
Methods for analysis of censored tumor growth delay data. Radiat Res (1990) 1.05
Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer. Lung Cancer (2006) 1.04
Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis. Strahlenther Onkol (1998) 1.01
DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathways. Strahlenther Onkol (2014) 0.99
Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis. J Cell Sci (2001) 0.99
Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis. Oncogene (2000) 0.99
Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines. Br J Cancer (2005) 0.98
Increased chromosome aberration levels in cells from mouse fetuses after zygote X-irradiation. Int J Radiat Biol (1989) 0.98
Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Oncogene (2001) 0.97
The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. II. Scanning and transmission electron microscopic studies. Acta Anat (Basel) (1989) 0.96
Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease. Eur J Med Res (2010) 0.96
One life saved by four prevented recurrences? Update of the Early Breast Cancer Trialists confirms: postoperative radiotherapy improves survival after breast conserving surgery. Strahlenther Onkol (2012) 0.95
Radiation sensitivity of lymphocytes from healthy individuals and cancer patients as measured by the comet assay. Radiat Environ Biophys (2001) 0.94
Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro. Int J Radiat Oncol Biol Phys (1997) 0.94
FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy. Eur J Nucl Med Mol Imaging (2002) 0.94
The vascular architecture of human xenotransplanted tumors: histological, morphometrical, and ultrastructural studies. J Cancer Res Clin Oncol (1990) 0.93
Current concepts in stereotactic radiosurgery - a neurosurgical and radiooncological point of view. Eur J Med Res (2009) 0.93
Thermoradiotherapy for locally recurrent breast cancer with skin involvement. Int J Hyperthermia (2001) 0.93
Micronuclei: a biological indicator of radiation damage. Mutat Res (1996) 0.93
Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors. Eur J Nucl Med Mol Imaging (2006) 0.93
Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice. J Cancer Res Clin Oncol (2001) 0.93
Radioresponsiveness of human glioma, sarcoma, and breast cancer spheroids depends on tumor differentiation. Int J Radiat Oncol Biol Phys (1993) 0.92
Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay. Br J Cancer (1994) 0.92
In vivo radiation sensitivity of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1995) 0.92
Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21(WAF1/CIP1). Cell Death Differ (2011) 0.91
Measurement of the grade of vascularisation in histological tumour tissue sections. Br J Cancer (1985) 0.91
DEGRO practical guidelines: radiotherapy of breast cancer II: radiotherapy of non-invasive neoplasia of the breast. Strahlenther Onkol (2014) 0.91
[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version]. Pneumologie (2011) 0.91
Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysis. Strahlenther Onkol (2012) 0.91
Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy. Eur J Med Res (2011) 0.90
Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice. Cancer Res (1993) 0.90
Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus. Oncology (1999) 0.90
A cytogenetic analysis of the long-term effect of uranium mining on peripheral lymphocytes using the micronucleus-centromere assay. Int J Radiat Biol (2001) 0.89
Polymorphisms in the p53 gene in thyroid tumours and blood samples of children from areas in Belarus. Mutat Res (1997) 0.89
The ICRP protection quantities, equivalent and effective dose: their basis and application. Radiat Prot Dosimetry (2007) 0.89
The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1. Cell Death Dis (2013) 0.89
New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma. Graefes Arch Clin Exp Ophthalmol (1990) 0.88
Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial. Br J Cancer (1999) 0.88
Automated comet assay analysis. Cytometry (1999) 0.88
Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time- and dose-dependent. Strahlenther Onkol (2012) 0.87
The role of prophylactic cranial irradiation in the treatment of lung cancer. Lung Cancer (2001) 0.87
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour. Eur Respir J (2006) 0.87
Evaluation of the tissue toxicity of antiseptics by the hen's egg test on the chorioallantoic membrane (HETCAM). Eur J Med Res (2010) 0.87
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma. Bone Marrow Transplant (2003) 0.87
Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus. Dis Esophagus (2013) 0.86
Radiation response in 10 high-grade human soft tissue sarcoma xenografts to photons and fast neutrons. Int J Radiat Oncol Biol Phys (1990) 0.86
Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial. Strahlenther Onkol (2013) 0.86
Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors. Radiother Oncol (1997) 0.86
Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer. Lung Cancer (2000) 0.86
Multifocal epithelioid hemangioendothelioma: case report of a clinical chamaeleon. Eur J Med Res (2006) 0.86
The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. I. Vascular corrosion casting studies. Acta Anat (Basel) (1989) 0.86
Comet assay studies indicate that caffeine-mediated increase in radiation risk of embryos is due to inhibition of DNA repair. Mutagenesis (1996) 0.86
Radiotherapy of soft tissue sarcomas with neutrons or a neutron boost. Br J Radiol (1984) 0.86
Gene expression of circulating tumour cells and its correlation with tumour stage in breast cancer patients. Eur J Med Res (2009) 0.86
Unilateral keloid formation after bilateral breast surgery and unilateral radiation. Eur J Med Res (2007) 0.86
The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation. Oncogene (1999) 0.86
NIR reflection measurements of hemoglobin and cytochrome aa3 in healthy tissue and tumors. Correlations to oxygen consumption: preclinical and clinical data. Adv Exp Med Biol (1997) 0.86
Prospective flow cytometric analysis of head and neck carcinomas. Prognostic relevance of DNA-content and S-fraction. J Craniomaxillofac Surg (1992) 0.85
Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO/ÖGRO). Strahlenther Onkol (2013) 0.85
Interdisciplinary treatment of primary hepatic angiosarcoma: emergency tumor embolization followed by elective surgery. Eur J Med Res (2007) 0.85
Oxidant-induced lung injury in anticancer therapy. Eur J Med Res (1999) 0.85
Mutations in the p53 tumour suppressor gene in thyroid tumours of children from areas contaminated by the Chernobyl accident. Int J Radiat Biol (1996) 0.85
Thermoradiotherapy of the chest wall in locally advanced or recurrent breast cancer with marginal resection. Int J Hyperthermia (2005) 0.85
The sensitivity of the in vitro cytokinesis-blocked micronucleus assay in lymphocytes for different and combined radiation qualities. Strahlenther Onkol (1998) 0.85